Compare · AONC vs OPCH
AONC vs OPCH
Side-by-side comparison of American Oncology Network Inc. (AONC) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AONC and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH carries a market cap of $3.15B.
- OPCH has hit the wire 13 times in the past 4 weeks while AONC has been quiet.
- OPCH has more recent analyst coverage (15 ratings vs 0 for AONC).
- Company
- American Oncology Network Inc.
- Option Care Health Inc.
- Price
- $2.25+25.00%
- $20.07-2.00%
- Market cap
- -
- $3.15B
- 1M return
- -
- -3.28%
- 1Y return
- -
- -36.63%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 15
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest AONC
- SEC Form 10-K filed by American Oncology Network Inc.
- Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
- SEC Form 15-15D filed by American Oncology Network Inc.
- Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
- Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation
- SEC Form EFFECT filed by American Oncology Network Inc.
- SEC Form S-8 POS filed by American Oncology Network Inc.
- SEC Form POS AM filed by American Oncology Network Inc.
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)